Preferred Label : CAPOX-Pembrolizumab-Trastuzumab Regimen;
NCIt synonyms : CAPOX/Pembrolizumab/Trastuzumab; CAPOX Plus Pembrolizumab Plus Trastuzumab Regimen; CAPOX-Pembrolizumab-Trastuzumab; CapeOx-Pembrolizumab-Trastuzumab Regimen; Capecitabine-Oxaliplatin-Pembrolizumab-Trastuzumab Regime; CAPOX-Keytruda-Herceptin;
NCIt related terms : CapeOx, Pembrolizumab, Trastuzumab; CapeOx, Pembrolizumab, Trastuzumab-pkrb; CapeOx, Pembrolizumab, Trastuzumab-zerc; CapeOx, Pembrolizumab, Trastuzumab-dkst; CapeOx, Pembrolizumab, Trastuzumab-dttb; CapeOx, Pembrolizumab, Trastuzumab-herw; CapeOx, Pembrolizumab, Trastuzumab-qyyp; CapeOx, Pembrolizumab, Trastuzumab-anns;
NCIt definition : A regimen consisting of capecitabine, oxaliplatin, pembrolizumab and trastuzumab that
may be used in the treatment of esophageal and esophagogastric junction and gastric
cancers.;
NCI Metathesaurus CUI : CL1922421;
Codes from synonyms : 59473; 129368; 129465; 129174; 129077; 128980; 128883; 129271;
Origin ID : C203545;
UMLS CUI : C5909313;
Semantic type(s)
chemotherapy_regimen_has_component
concept_is_in_subset